Mirum Pharmaceuticals (MIRM) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free MIRM Stock Alerts $24.49 +0.47 (+1.96%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mirum Pharmaceuticals Short Interest DataCurrent Short Volume8,580,000 sharesPrevious Short Volume8,160,000 sharesChange Vs. Previous Month+5.15%Dollar Volume Sold Short$205.15 millionShort Interest Ratio / Days to Cover17.2Last Record DateApril 15, 2024Outstanding Shares47,120,000 sharesPercentage of Shares Shorted18.21%Today's Trading Volume817,234 sharesAverage Trading Volume402,064 sharesToday's Volume Vs. Average203% Short Selling Mirum Pharmaceuticals ? Sign up to receive the latest short interest report for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMIRM Short Interest Over TimeMIRM Days to Cover Over TimeMIRM Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Mirum Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,580,000 shares $205.15 million +5.2%N/A17.2 $23.91 3/31/20248,160,000 shares $204.98 million +0.3%N/A13.9 $25.12 3/15/20248,140,000 shares $217.91 million +6.3%N/A13.5 $26.77 2/29/20247,660,000 shares $219.92 million -1.5%N/A11.9 $28.71 2/15/20247,780,000 shares $225.46 million -0.9%N/A11.9 $28.98 1/31/20247,850,000 shares $207.71 million +8.0%N/A11.6 $26.46 Get the Latest News and Ratings for MIRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,270,000 shares $198.40 million +0.6%N/A10.8 $27.29 12/31/20237,230,000 shares $213.43 million +4.2%N/A12.1 $29.52 12/15/20236,940,000 shares $242.41 million +12.5%N/A12.3 $34.93 11/30/20236,170,000 shares $197.87 million -3.0%N/A11.2 $32.07 11/15/20236,360,000 shares $193.09 million +4.6%N/A12.2 $30.36 10/31/20236,080,000 shares $166.77 million -2.6%22.6%12.4 $27.43 10/15/20236,240,000 shares $175.47 million +4.9%24.7%12.3 $28.12 9/30/20235,950,000 shares $188.02 million +8.2%23.5%10.2 $31.60 9/15/20235,500,000 shares $180.68 million +8.3%21.8%9.4 $32.85 8/31/20235,080,000 shares $134.26 million +0.6%20.2%9 $26.43 8/15/20235,050,000 shares $129.73 million +24.7%18.7%9.4 $25.69 7/31/20234,050,000 shares $104.33 million +35.0%14.9%7.5 $25.76 7/15/20233,000,000 shares $78.75 million -8.0%11.1%5.7 $26.25 6/30/20233,260,000 shares $84.34 million +10.1%12.1%5.3 $25.87 6/15/20232,960,000 shares $83.15 million +0.7%11.0%5.1 $28.09 5/31/20232,940,000 shares $77.12 million -7.3%11.8%5.6 $26.23 5/15/20233,170,000 shares $82.52 million +1.6%12.7%6.4 $26.03 4/30/20233,120,000 shares $83.77 million +4.4%13.0%6.6 $26.85 4/15/20232,990,000 shares $74.72 million +69.9%12.5%6.3 $24.99 3/31/20231,760,000 shares $42.28 million -10.2%7.2%4.5 $24.02 3/15/20231,960,000 shares $46.31 million +7.1%8.0%6.5 $23.63 2/28/20231,830,000 shares $43.02 million -2.7%7.7%5.7 $23.51 2/15/20231,880,000 shares $42.41 million +14.6%7.9%5.6 $22.56 1/31/20231,640,000 shares $38.51 million +42.6%7.1%4.5 $23.48 1/15/20231,150,000 shares $25.30 million +9.5%4.9%3.2 $22.00 12/30/20221,050,000 shares $20.48 million -13.2%4.5%2.8 $19.50 12/15/20221,210,000 shares $21.62 million -18.8%5.3%3.1 $17.87 11/30/20221,490,000 shares $27.79 million -11.8%6.6%3.7 $18.65 11/15/20221,690,000 shares $33.85 million -8.2%7.4%4.3 $20.03 10/31/20221,840,000 shares $41.49 million -10.2%8.2%4.4 $22.55 10/15/20222,050,000 shares $39.20 million -18.3%9.2%5 $19.12 9/30/20222,510,000 shares $52.74 million +6.4%11.2%6.6 $21.01 9/15/20222,360,000 shares $54.09 million +0.9%10.5%7.1 $22.92 8/31/20222,340,000 shares $58.45 million +8.3%11.4%7.9 $24.98“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). MIRM Short Interest - Frequently Asked Questions What is Mirum Pharmaceuticals' current short interest? Short interest is the volume of Mirum Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 8,580,000 shares of MIRM short. Learn More on Mirum Pharmaceuticals' current short interest. What is a good short interest ratio for Mirum Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIRM shares currently have a short interest ratio of 17.0. Learn More on Mirum Pharmaceuticals's short interest ratio. Which institutional investors are shorting Mirum Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirum Pharmaceuticals: Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mirum Pharmaceuticals' short interest increasing or decreasing? Mirum Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 8,580,000 shares, an increase of 5.1% from the previous total of 8,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mirum Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mirum Pharmaceuticals: AbCellera Biologics Inc. (11.25%), MannKind Co. (13.21%), Xencor, Inc. (10.18%), Collegium Pharmaceutical, Inc. (22.86%), Deciphera Pharmaceuticals, Inc. (11.45%), Prothena Co. plc (12.34%), Pieris Pharmaceuticals, Inc. (0.03%), Belite Bio, Inc (0.12%), Ligand Pharmaceuticals Incorporated (4.98%), Spyre Therapeutics, Inc. (10.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mirum Pharmaceuticals stock? Short selling MIRM is an investing strategy that aims to generate trading profit from Mirum Pharmaceuticals as its price is falling. MIRM shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mirum Pharmaceuticals? A short squeeze for Mirum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MIRM, which in turn drives the price of the stock up even further. How often is Mirum Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIRM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AbCellera Biologics Short Interest Data MannKind Short Interest Data Xencor Short Interest Data Collegium Pharmaceutical Short Interest Data Deciphera Pharmaceuticals Short Interest Data Prothena Short Interest Data Pieris Pharmaceuticals Short Interest Data Belite Bio Short Interest Data Ligand Pharmaceuticals Short Interest Data Spyre Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MIRM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets